# Labetalol and Esmolol: Vital Signs and Post Operative Pain Management

> **NCT01114971** · PHASE4 · COMPLETED · sponsor: **Cedars-Sinai Medical Center** · enrollment: 75 (actual)

## Conditions studied

- Laparoscopic Surgery

## Interventions

- **DRUG:** Fentanyl
- **DRUG:** Labetalol
- **DRUG:** Esmolol

## Key facts

- **NCT ID:** NCT01114971
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09-03
- **Primary completion:** 2014-07-30
- **Final completion:** 2018-07-31
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2020-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01114971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01114971, "Labetalol and Esmolol: Vital Signs and Post Operative Pain Management". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01114971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*